Shares of Verici Dx plc (LON:VRCI – Get Free Report) were up 14.1% during trading on Tuesday . The company traded as high as GBX 4.92 ($0.06) and last traded at GBX 4.85 ($0.06). Approximately 235,418 shares changed hands during trading, a decline of 33% from the average daily volume of 350,158 shares. The stock had previously closed at GBX 4.25 ($0.05).
Verici Dx Trading Up 29.4 %
The company has a debt-to-equity ratio of 4.65, a quick ratio of 8.49 and a current ratio of 4.54. The company has a market capitalization of £13.34 million, a price-to-earnings ratio of -275.00 and a beta of 1.59. The business’s 50 day moving average price is GBX 3.11 and its two-hundred day moving average price is GBX 5.28.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- Do ETFs Pay Dividends? What You Need to Know
- These 3 Airline Stocks Have Analysts Feeling Bullish for 2025
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Raytheon the Best Defense and Aerospace Stock to Own in 2025?
- How to Invest in Blue Chip Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
